Acute myeloid leukemia with mutated nucleophosmin 1: an immunogenic acute myeloid leukemia subtype and potential candidate for immune checkpoint inhibition

被引：25
|
作者：
Greiner, Jochen [1 ,2 ]
Hofmann, Susanne [1 ,3 ]
Schmitt, Michael [3 ]
Goetz, Marlies [1 ]
Wiesneth, Markus [4 ,5 ]
Schrezenmeier, Hubert [4 ,5 ]
Bunjes, Donald [1 ]
Doehner, Hartmut [1 ]
Bullinger, Lars [1 ]
机构：
[1] Univ Ulm, Dept Internal Med 3, Ulm, Germany
[2] Diakonie Hosp Stuttgart, Dept Internal Med, Stuttgart, Germany
[3] Heidelberg Univ, Dept Internal Med 5, Heidelberg, Germany
[4] Baden Wurttemberg Hessen, German Red Cross Blood Transfus Serv, Inst Clin Transfus Med & Immunogenet Ulm, Ulm, Germany
[5] Inst Transfus Med, Ulm, Germany
来源：
HAEMATOLOGICA | 2017年 / 102卷 / 12期
关键词：
T-CELL RESPONSES; CANCER; AML; BLOCKADE; DONOR; PD-1;
D O I：
10.3324/haematol.2017.176461
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：499 / 501
页数：3
相关论文
共 50 条
  • [1] Immune Response in Acute Myeloid Leukemia with Mutated Nucleophosmin
    Kuzelova, Katerina
    Brodska, Barbora
    Markova, Jana
    Helbig, Crzegorz
    Kyrcz-Krzemien, Slawomira
    Cetkovsky, Petr
    BLOOD, 2015, 126 (23)
  • [2] Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia
    van der Lee, Dyantha, I
    Reijmers, Rogier M.
    Honders, Maria W.
    Hagedoorn, Renate S.
    de Jong, Rob C. M.
    Kester, Michel G. D.
    van der Steen, Dirk M.
    de Ru, Arnoud H.
    Kweekel, Christiaan
    Bijen, Helena M.
    Jedema, Inge
    Veelken, Hendrik
    van Veelen, Peter A.
    Heemskerk, Mirjam H. M.
    Falkenburg, J. H. Frederik
    Griffioen, Marieke
    JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (02): : 774 - 785
  • [3] Quantitative Assay of Mutated Nucleophosmin in Acute Myeloid Leukemia
    Khaled, Safaa A. A.
    Burthem, John
    Elnoor, El-Badry E. Abo
    ElToni, Lobna F.
    Ahmed, Hanan M.
    Ahmed, Sohier M.
    JOURNAL OF HEMATOLOGY, 2019, 8 (03) : 111 - 120
  • [4] Immunosuppressive mechanisms in acute myeloid leukemia with mutated nucleophosmin
    Kuzelova, K.
    Brodska, B.
    Otevrelova, P.
    Salek, C.
    ANNALS OF ONCOLOGY, 2018, 29
  • [5] Immune Checkpoint Inhibition in Acute Myeloid Leukemia and Myelodysplastic Syndromes
    Abaza, Yasmin
    Zeidan, Amer M.
    CELLS, 2022, 11 (14)
  • [6] Nucleophosmin 1 Mutations in Acute Myeloid Leukemia
    Zarka, Jabra
    Short, Nicholas J.
    Kanagal-Shamanna, Rashmi
    Issa, Ghayas C.
    GENES, 2020, 11 (06) : 1 - 16
  • [7] Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity?
    Falini, Brunangelo
    Martelli, Maria Paola
    Bolli, Niccolo
    Sportoletti, Paolo
    Liso, Arcangelo
    Tiacci, Enrico
    Haferlach, Torsten
    BLOOD, 2011, 117 (04) : 1109 - 1120
  • [8] Immune Checkpoint Inhibitors in Acute Myeloid Leukemia
    Bhatt, Vijaya Raj
    ONCOLOGY-NEW YORK, 2019, 33 (01): : 30 - 30
  • [9] Immune checkpoint inhibitors in acute myeloid leukemia
    Daver, Naval
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2021, 34 (01)
  • [10] Role of nucleophosmin in acute myeloid leukemia
    Meani, Natalia
    Alcalay, Myriam
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (09) : 1283 - 1294
12345